Podcasts about Young

The Breaking Points team discusses the NYC mayoral debate between Cuomo, Zohran and Sliwa, the "young" Republican group chat leaks, and we're joined again by Delaware's State Rep Medinah Wilson-Anton who recently did a stand up set on Kill Tony. Follow Medinah: https://www.instagram.com/madinahfordelaware/ To become a Breaking Points Premium Member and watch/listen to the show AD FREE, uncut and 1 hour early visit: www.breakingpoints.comMerch Store: https://shop.breakingpoints.com/See omnystudio.com/listener for privacy information.

CORRECTION: OAN signed Hegseth's agreement, not Newsmax.THE GROUP CHAT GOT LEAKED!!! The HITO men talk about a massive group chat leak from members of the “Young” Republican organization, the continuing government shutdown, SCOTUS looking to further gut the Voting Rights Act, and updates from the shaky Gaza ceasefire situation. Check out the Patreon for early access to episodes, leave a 5-star review on Apple, and follow our other socials!Patreon: https://www.patreon.com/headintheofficepodHITO Merch: https://headintheoffice.com/ Get 40% off Ground News: https://ground.news/checkout/all?fpr=headintheoffice YouTube: https://www.youtube.com/channel/UC4iJ-UcnRxYnaYsX_SNjFJQTikTok: https://www.tiktok.com/@headintheoffice?lang=enInstagram: https://www.instagram.com/headintheoffice/Twitter: https://twitter.com/headintheofficeBluesky: https://bsky.app/profile/headintheoffice.bsky.social Discord: https://discord.gg/hito Collab inquiries: headintheofficepod@gmail.comSeen on this episode:Government shutdown - https://apnews.com/article/poll-government-shutdown-blame-trump-republicans-democrats-12c01432bbb43746b6d8d32390c959f4https://www.politico.com/live-updates/2025/10/16/congress/shutdown-strategy-defense-appropriations-bill-minibus-00611131 https://www.cnbc.com/2025/10/15/judge-trump-jobs-government-shutdown.html SCOTUS - https://www.npr.org/2025/10/15/nx-s1-5575101/scotus-voting-rights-argumentsBrief Gaza update - https://abcnews.go.com/world-news-tonight-with-david-muirT/video/trump-hamas-disarm-disarmed-violently-126530903https://time.com/7326104/israel-hamas-deal-gaza-trump-ceasefire-hostages/https://www.cnn.com/world/live-news/israel-gaza-ceasefire-deal-hostages-10-15-25Dave Taylor flag - https://www.thedailybeast.com/swastika-flag-spotted-in-maga-rep-dave-taylors-office-sparks-investigation/ Pentagon reporting rules - https://apnews.com/article/pentagon-press-access-hegseth-trump-restrictions-5d9c2a63e4e03b91fc1546bb09ffbf12https://www.pbs.org/newshour/show/why-news-organizations-are-rejecting-the-pentagons-new-press-rules

This week, Jackie Broyles and Dunlap yell about: J.D. Vance defends Young Republican racist texts. Is the Supreme Court about to get rid of the Voting Rights Act? Pete Hegseth kicks the press out of the Pentagon. Russell Vought uses government shutdown to gut Department of Education and their special ed department. Trump afraid he won't go to heaven, hates his Time cover. Are we going to war with Venezuela? What's up with Argentina? No Kings protests this weekend. Get 20 Extra Minutes with Jackie & Dunlap at http://patreon.com/redstateupdate Get you a Jackie Barrel shirt at http://redstateupdate.myshopify.com music by william sherry jr. art by yoni limor. photos by robyn von swank.

Welcome to PTBN Pop's Video Jukebox Song of The Day! Every weekday will be featuring a live watch of a great and memorable music video. On today's episode, Andy Atherton is watching “Too Young To Fall In Love” by Motley Crue from 1983.   The YouTube link for the video is below so you can watch along! https://www.youtube.com/watch?v=d25tXdJSedE

Gen Z and millennial voters are a significant voting bloc — expected to account for more than half of eligible voters by the next presidential election. We discuss how the financial pressures weighing specifically on younger rural voters affects how and whether they vote.This episode: political correspondent Ashley Lopez, political reporter Elena Moore, and senior political editor and correspondent Domenico Montanaro.This podcast was produced by Casey Morell & Bria Suggs, and edited by Rachel Baye. Our executive producer is Muthoni Muturi.Listen to every episode of the NPR Politics Podcast sponsor-free, unlock access to bonus episodes with more from the NPR Politics team, and support public media when you sign up for The NPR Politics Podcast+ at plus.npr.org/politics.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Evan, Canty, & Michelle wonder if the Cowboys can become a playoff contender in an NFC East that might be down right now. Evan has qualms with planning for his kids' sporting events and Terron Armstead joins the show to give an inside look to the dysfunction on and off the field for the Dolphins. Canty's Best Bet & UnSportsmanLike Moments of the Day: NHL mascots are wildin' out! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Evan, Canty, & Michelle wonder if the Cowboys can become a playoff contender in an NFC East that might be down right now. Evan has qualms with planning for his kids' sporting events and Terron Armstead joins the show to give an inside look to the dysfunction on and off the field for the Dolphins. Canty's Best Bet & UnSportsmanLike Moments of the Day: NHL mascots are wildin' out! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Daggers are out for Sen. John Fetterman as Democrats are plotting to primary him. CNN's had a disastrous town hall where Bernie and AOC had a full-on meltdown. NBC News cuts 7% of their staff including their DEI department. Dana breaks down the angles surrounding the Politico piece exposing text messages in the Young Republicans' group chats and calls out the anti-Semitic “woke right” who are making idols out of bigots. Dana goes scorched Earth on how the new fad of being anti-Semitic isn't “edgy”. Zohran Mamdani faces the gauntlet on Fox News to defend his radical policy proposals. Justice Ketanji Brown Jackson rules that race should determine Congressional districts because black voters are disabled. Nancy Pelosi screams at a Congressional reporter to “shut up”.Thank you for supporting our sponsors that make The Dana Show possible…Boll&Branchhttps://BollandBranch.com/danashow Start building your sanctuary of comfort this fall with Boll & Branch. For a limited time get 20% off your first set of sheets plus free shipping.Webroothttps://Webroot.com/danaChange your October from cyber-scary to cyber-secure with 60% off Webroot Total Protection.AmmoSquaredhttps://AmmoSquared.comDon't get caught without ammo and be sure to tell them you heard about Ammo Squared on this show. PreBornhttps://PreBorn.com/DANA Or DIAL #250 Say the keyword BABY. That's #250, BABY. Together, we can save lives — one mom and one baby at a time.ChapterFor free and unbiased Medicare help from my partners Chapter, dial #250 and say keyword “My Medicare”Chapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand-alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently, we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options.Keltechttps://KelTecWeapons.comKelTec builds every KS7 GEN2 right here in the USA with American materials and workers—upgrade your home defense today. All Family Pharmacyhttps://AllFamilyPharmacy.com/Dana Don't wait until flu season knocks at your door. Use code DANA10 at checkout to save 10%. Relief Factorhttps://ReliefFactor.com OR CALL 1-800-4-RELIEFTurn the clock back on pain with Relief Factor. Get their 3-week Relief Factor Quick Start for only $19.95 today! Byrnahttps://Byrna.com/danaGet your hands on the new compact Byrna CL. Visit Byrna.com/Dana to receive 10% off. Patriot Mobilehttps://PatriotMobile.com/DanaDana's personal cell phone provider is Patriot Mobile. Get a FREE MONTH of service code DANAHumanNhttps://HumanN.comStart supporting your cardiovascular health with SuperBeets now available at your local Wal

The Supreme Court hears arguments about race-based redistricting. New polling suggests America's youth have soured on the transgender agenda. Young liberals think committing murder to stop ICE deportations of illegal aliens is justified. Bernie and AOC host a town hall to convince what's left of CNN's viewership that Republicans are to blame for everything.

Evan, Canty, & Michelle wonder if the Cowboys can become a playoff contender in an NFC East that might be down right now. Evan has qualms with planning for his kids' sporting events and Terron Armstead joins the show to give an inside look to the dysfunction on and off the field for the Dolphins. Canty's Best Bet & UnSportsmanLike Moments of the Day: NHL mascots are wildin' out! Learn more about your ad choices. Visit podcastchoices.com/adchoices

YIKES! Someone leaked the Young Republicans group chat, and some of the messages are NOT GOOD. However, there are a few jokes that actually landed! We dig into the leaked messages. Joined in studio by comedians Robbie Mann and Reese Jeffries, we discuss how and why these messages were leaked in the first place. Finally, we have Indian musical sensation DPAK perform his “Trumpty Dance” song! Don't miss this episode of “Prime Time with Alex Stein”!   Today's Sponsors:  CraftCo Fox & Oden Flying Ace bourbon isn't about trends — it's about legacy. Bold, balanced, and unapologetically American, it's the real whiskey for those who value hard work and high standards. Buy now at https://flyingacespirits.com and use code BLAZE for free shipping. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode is presented by Create A Video – Leaked text messages among Young Republicans published in POLITICO prompts outrage by Democrats who cannot seem to be outraged over Jay Jones' violence fantasies. Help Pete’s Walk to End Alzheimer’s! Subscribe to the podcast at: https://ThePetePod.com/ All the links to Pete's Prep are free: https://patreon.com/petekalinershow Media Bias Check: GroundNews promo code! Advertising and Booking inquiries: Pete@ThePeteKalinerShow.com Get exclusive content here!: https://thepetekalinershow.com/See omnystudio.com/listener for privacy information.

Seriously? These 3 clowns are sages? The discussion includes how to select the "right” school. How much should a school include building science compared to learning it on the job? And what about even just the 4 control layers?  And all three of us stand squarely with Steve: if you want to design buildings, get out on the job site first, second, and last over the course of your prep and your years on the job. And then take what you learn at the site to improve the information transfer you accomplish with your drawings!PETE'S RESOURCES:The architecture school Steve went toPete taught for Keene State in building science (briefly)ACSA (Assoc of Collegiate Schools of Architecture): cool resource including a Quiz that leads you to schools that reflect what you want out of your architecture educationNICHE Building Science and Technology Graduate Programs in AmericaBuildingScience Newsletter: sign up by scrolling to the very bottom of their home page

It's Thursday, October 16th, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Jonathan Clark British Christian teacher fired for Facebook post about Islamic violence A British Christian teacher, who was unjustly  fired, shared his testimony at a Reform UK party free speech conference last week. Simon Pearson had a 20-year unblemished teaching record. However, Preston College dismissed him last year for allegedly being “Islamaphobic.” He had simply expressed concern on Facebook over violent crime and political bias. Pearson is challenging his dismissal with the help of the Christian Legal Centre.  Listen to his comments at the free speech conference. PEARSON: “Previously, I've worked as a missionary in a communist country where freedom of speech and religion are tightly controlled. I know what it means to live under a regime where truth is suppressed and conscience is punished. “I never imagined I would face similar pressures in the United Kingdom, a country built on the foundations of liberty, of justice and of Christian values. I'm fighting for justice, not just for myself, but for every teacher, for every Christian and every citizen who fears that their voice no longer matters and they are being silenced.” Young people of Northern Ireland more open to Christianity Speaking of the United Kingdom, young people in Northern Ireland are leading a revival of interest in Christianity, according to a poll by The Iona Institute. The survey found 18-24-year-olds in Northern Ireland are more likely to have a very positive attitude toward Christianity than any other age group. These findings are similar to studies of young people in Ireland, Britain, and the United States. Gen Z boys most likely to believe that Jesus is way to Heaven Here in America, the Barna Group released new research from its ongoing State of the Church initiative.  Surveys show that Gen Z is increasingly open to Christian faith. However, among young people, women are the most likely to disengage from church, prayer, and belief.  Meanwhile, young men and especially teenage boys are the least likely to identify as having no faith among young people. They are also the most likely to believe in God and that Jesus Christ is the only way to God. In John 14:6, Jesus said, “I am the way, the truth, and the life. No one comes to the Father except through Me.” Fewer young Americans identifying as “transgender” Here some more good news. Trans identification is declining among young people in America. Eric Kaufmann, a Canadian professor of politics, posted the findings on Tuesday. His analysis is based on multiple data sets, including those from the Foundation for Individual Rights and Expression. The data shows 3.6% of undergraduates identify as a gender other than male or female. That's down from 5.2% in 2024 and 6.8% in 2022.  The data sets also showed young people are becoming less likely to identify as something other than heterosexual.  Trump posthumously awarded Charlie Kirk Presidential Medal of Freedom President Donald Trump posthumously awarded Charlie Kirk with the Presidential Medal of Freedom on Tuesday. Kirk's widow, Erika, received the nation's highest civilian medal on his behalf on what would have been his 32nd birthday.  The ceremony comes about a month after the Christian activist was fatally shot while speaking at an event for his organization, Turning Point USA.  Listen to comments from President Trump. TRUMP: “Charlie never missed an opportunity to remind us of the Judeo-Christian principles of our nation's founding or to share his deep Christian faith. In his final moments, Charlie testified to the greatness of America and to the glory of our Savior with Whom he now rests in Heaven. Anniversary of martyrdom of two English reformers And finally, today is the anniversary of the martyrdom of two English Reformers. Their names were Hugh Latimer and Nicholas Ridley. Both were bishops in the Church of England. Ridley was born in 1502, becoming a great scholar and renouncing Roman Catholic doctrine. Latimer was born earlier in 1485. He became a great Reformation preacher, also rejecting Catholic traditions. His preaching brought Protestant teachings effectively to the middle and lower classes. However, a Catholic queen came to power in England in 1553. She was known as “Bloody Mary” for her deadly persecution of Protestants. After her ascension to power, Latimer and Ridley were tried for their beliefs and burned at the stake on October 16, 1555. As they faced death together, Latimer told his friend, “Be of good comfort, Master Ridley, and play the man; we shall this day light such a candle, by God's grace, in England, as I trust shall never be put out.” In Romans 8:36-37, the Apostle Paul wrote, “As it is written: ‘For Your sake we are killed all day long; we are accounted as sheep for the slaughter.' Yet in all these things we are more than conquerors through Him who loved us.” Close And that's The Worldview on this Thursday, October 16th, in the year of our Lord 2025, the 60th wedding anniversary of my parents, Mike and Harriet McManus, with whom I will celebrate this very weekend.  Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Evan, Canty, & Michelle wonder if the Cowboys can become a playoff contender in an NFC East that might be down right now. Evan has qualms with planning for his kids' sporting events and Terron Armstead joins the show to give an inside look to the dysfunction on and off the field for the Dolphins. Canty's Best Bet & UnSportsmanLike Moments of the Day: NHL mascots are wildin' out! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Evan, Canty, & Michelle wonder if the Cowboys can become a playoff contender in an NFC East that might be down right now. Evan has qualms with planning for his kids' sporting events and Terron Armstead joins the show to give an inside look to the dysfunction on and off the field for the Dolphins. Canty's Best Bet & UnSportsmanLike Moments of the Day: NHL mascots are wildin' out! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Nancy Pelosi loses it on a young reporter, shouting “shut up!” when pressed about January 6. Meanwhile, Justice Ketanji Brown Jackson shocks the nation by comparing black Americans to the disabled in Supreme Court arguments. As Democrats unravel and Fetterman becomes their most “normal” voice, Mike breaks down the left’s public meltdown and what it means for 2024.See omnystudio.com/listener for privacy information.

Episode Summary: Chris Lettman of Imperial Star Solar, an American-made solar module manufacturer, joins Benoy on the Solar Maverick Podcast to unpack how projects truly qualify for the 10% domestic content adder, why U.S. cells and traceability drive eligibility, and what U.S. manufacturing looks like at Imperial Star's Houston facility. They also discuss supply realities, Tier 1 vs. bankability, and practical insights for developers and EPCs when procuring panels. Biographies Benoy Thanjan Benoy Thanjan is the Founder and CEO of Reneu Energy, solar developer and consulting firm, and a strategic advisor to multiple cleantech startups. Over his career, Benoy has developed over 100 MWs of solar projects across the U.S., helped launch the first residential solar tax equity funds at Tesla, and brokered $45 million in Renewable Energy Credits (“REC”) transactions. Prior to founding Reneu Energy, Benoy was the Environmental Commodities Trader in Tesla's Project Finance Group, where he managed one of the largest environmental commodities portfolios. He originated REC trades and co-developed a monetization and hedging strategy with senior leadership to enter the East Coast market. As Vice President at Vanguard Energy Partners, Benoy crafted project finance solutions for commercial-scale solar portfolios. His role at Ridgewood Renewable Power, a private equity fund with 125 MWs of U.S. renewable assets, involved evaluating investment opportunities and maximizing returns. He also played a key role in the sale of the firm's renewable portfolio. Earlier in his career, Benoy worked in Energy Structured Finance at Deloitte & Touche and Financial Advisory Services at Ernst & Young, following an internship on the trading floor at D.E. Shaw & Co., a multi billion dollar hedge fund. Benoy holds an MBA in Finance from Rutgers University and a BS in Finance and Economics from NYU Stern, where he was an Alumni Scholar. Chris Lettman Sales Manager Chris serves as the Sales Manager of the US office at Imperial Star with a primary focus on Utility Scale and C&I clients. He started his solar energy career in 2009 selling turnkey systems to residential and mid-size commercial properties. Since that time, he has been involved in the development, acquisition and construction of numerous large utility scale and commercial scale solar projects throughout the United States. Chris has extensive experience and knowledge in the areas of project development, project finance and equipment sales. Prior to starting his career in the solar industry, Chris was a marketing manager for a publicly held pharmaceutical company in the United States. He is a U.S. Marine Corps veteran and served in Southwest Asia during Operation Desert Shield/Desert Storm. He holds an MBA in Business from the University of Redlands California and currently lives in Southern California.   Stay Connected: Benoy Thanjan Email: info@reneuenergy.com  LinkedIn: Benoy Thanjan Website: https://www.reneuenergy.com   Chris Lettman Linkedin: https://www.linkedin.com/in/chrislettman/ Website:  https://www.imperialstar.com/

Today on Mommywood, we're joined by the incredible Alysha Young — actor, podcaster, and founder of Love Talent Mama. You might know her as the voice behind the ‘Acting Like a Mom' podcast, where she keeps it real about juggling motherhood and the entertainment industry. Alysha's a mom of two young kids, and somehow still finds time to inspire other moms in the biz with her honesty, humor, and heart. We're diving into what it means to chase your creative dreams while raising tiny humans — and how she's building a supportive space for moms who get it.Chapters00:00 Introduction and Podcast Naming Journey02:39 Navigating Motherhood in the Acting Industry05:41 The Challenges of Balancing Family and Career08:34 Deciding to Have Children as Actors11:32 Experiences of Pregnancy and Early Motherhood14:34 The Impact of Children on Relationships17:31 Auditioning with Kids and Family Dynamics20:25 The Decision to Move for Family and Career23:19 The Reality of Self-Taping and Auditioning26:07 Navigating the Industry as a Family29:13 The Emotional Journey of Motherhood31:50 Advice for Aspiring Parents in the Industry34:42 The Joys and Challenges of Parenting37:33 Final Thoughts on Family and CareerTakeawaysThe podcast name reflects the challenges of motherhood in acting.There is a growing community of mothers in the acting industry.Balancing family and career is a common struggle for actors.Pregnancy can change one's perspective on career aspirations.Having children can enhance life experiences, not hinder them.Communication is key in relationships when raising children.Self-taping has changed the audition landscape for actors.It's important to give oneself grace during parenting challenges.The love for children can be overwhelming and transformative.Deciding to have children should not be solely based on career considerations.

A new poll shows 60 percent of liberals under the age of 30 support violence against policies they don't like. Kamala Harris thinks she's the most qualified person to ever run for president. And talks on the violent weekend in Mississippi.

Prime Minister Mark Carney and Ontario Premier Doug Ford are meeting this morning to discuss trade and tackling crime. Health ministers from across the country are in Calgary, taking stock of Canada's healthcare system. Canadian Real Estate Association report shows drop in homes sales in September. Young families across Canada flee urban life for cheaper housing in smaller communities. Officials in Israel confirm two bodies returned by Hamas last night are those of dead hostages. Afghanistan and Pakistan have agreed to a temporary ceasefire following a week of clashes. Venezuela president Nicolas Maduro warns US president Donald Trump from carrying out a CIA coup in his country. The Toronto Blue Jays beat the Seattle Mariners 13-4 in game 3 of the ALCS.

Be Flexible Mark Zoril Podcast Episode: #34 Podcast Date: 10/16/2025

Today on Truth in Politics and Culture, President Trump prepares for a meeting with President Zelensky at the White House. The topic will be Ukraine receiving tomahawk missiles and more air defense capabilities, The Mexican drug cartels are using Chicago gangs to go after federal agents, Young republicans are demonstrating a disturbing trend toward racism in online chats. Does it belong in the same category as the disgusting remarks made by Virginia Attorney General candidate Jay Jones?

BLEAV in Hornets with Will "Dolla Bill" Bush is your go-to podcast for all things Charlotte Hornets. Hosted by Will Bush, today's episode brings you DOLLA'S DYNAMIC OFF SEASON ADDITIONS for the team, and which young PHENOM is on the RISE for the upcoming NBA season! Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Women materialising out of a fire place and nodding a hello to the house owners as she walks past them and through the other wall. Young teenagers walking through fields encounter a 40 foot giant man screaming in terror at the sky, causing them and the cows to run for cover! Just some of the topics discussed in this month's Paranormal Peep Show. Returning guest, author and researcher Andy Thomas, introduces us to his most recent book entitled 'Strange: Paranormal Realities in the Everyday World'. Andy looks freshly at the paranormal with incisive analysis to make the case that encounters with it are far more common than is commonly acknowledged and that they urgently need re-evaluation. With over 35 years of research, Andy has met countless witnesses and now it is time for their stories to be told. Sceptics, please block your ears. It might disturb your sense of chaos! Using up to date evidence and with the help of a panel of open-minded scientific experts, 'Strange' delves into many previously unrecorded true-life tales from around the world. Ghosts, UFOs, psychic powers, out-of-body-experiences and beyond, 'Strange' constitutes one of the broadest and most insightful assessments of unexplained phenomena ever carried out, investigating their possible causes and profound implications.Andy Thomas's work can be found athttps://truthagenda.org/ Become a supporter of this podcast: https://www.spreaker.com/podcast/paranormal-uk-radio-network--4541473/support.

https://teachhoops.com/ Steve Collins is the varsity Boys Basketball Coach at Madison Memorial High School in Madison Wisconsin. He is in his 25th year as a varsity coach. has a coaching record of 492_ 152 . His teams have won 14 conference championships, has 4 state runner up finishes and 3 State championship in 10 State appearances You can find him ⁠ www.teachhoops.com⁠ ⁠ www.coachingyouthhoops.com⁠ ⁠ Coaching Store⁠ ⁠Free Facebook Group⁠ (Basketball Coaches) ⁠ Twitter⁠ ⁠ Youtube⁠ ⁠Teachhoops.com⁠ ⁠Wintheseason.com⁠ ⁠Facebook Group⁠ ⁠Youtube Channel⁠ ⁠Teachhoops BLOG⁠ Podcasts ⁠High School Hoops⁠ ⁠Basketball Coach Unplugged⁠ ⁠5 Min Basketball Coaching Podcast⁠ ⁠Funnel Down Defense⁠ ⁠Rule of 3 Offense⁠ ⁠Coaching Youth Hoops⁠ ⁠https://forms.gle/kQ8zyxgfqwUA3ChU7⁠ ⁠Coach Collins Coaching Store⁠ ⁠Twitter⁠ Check out.  [Teachhoops.com](⁠https://teachhoops.com/⁠) 14 day Free Trial Youth Basketball Coaches Podcast Apple link: ⁠https://podcasts.apple.com/us/podcast/coaching-youth-hoops/id1619185302⁠ Spotify link: ⁠https://open.spotify.com/show/0g8yYhAfztndxT1FZ4OI3A⁠ ⁠Funnel Down Defense Podcast⁠ ⁠https://podcasts.apple.com/us/podcast/funnel-down-defense/id1593734011⁠ Want More ⁠Funnel Down Defense⁠ ⁠https://coachcollins.podia.com/funnel-down-defense⁠ [Facebook Group . Basketball Coaches](⁠https://www.facebook.com/groups/basketballcoaches/)⁠ [Facebook Group . Basketball Drills](⁠https://www.facebook.com/groups/321590381624013/)⁠ Want to Get a Question Answered? [ Leave a Question here](⁠https://www.speakpipe.com/Teachhoops⁠) Check out our other podcast [High School Hoops ](⁠https://itunes.apple.com/us/podcast/high-school-hoops-coaching-high-school-basketball/id1441192866⁠) Check out our Sponsors [HERE](https://drdishbasketball.com/) Mention Coach Unplugged and get 350 dollars off your next purchase Becoming a Head Basketball Coach basketball resources free basketball resources Coach Unplugged Basketball drills, basketball coach, basketball workouts, basketball dribbling drills,  ball handling drills, passing drills, shooting drills, basketball training equipment, basketball conditioning, fun basketball games, basketball jerseys, basketball shooting machine, basketball shot, basketball ball, basketball training, basketball camps, youth basketball, youth basketball leagues, basketball recruiting, basketball coaching jobs, basketball tryouts, basketball coach, youth basketball drills, The Basketball Podcast, How to Coach Basketball, Funnel Down Defense FDD Learn more about your ad choices. Visit podcastchoices.com/adchoices

Young me always wanted to be a hero.  Protecting the innocent, standing up to villainy, proud of my words and deeds.  Maybe I got a little jaded for a bit, but in my older/wiser years I am trying to revert to my younger desire and at least be a sometimes-mediocre sidekick of a quality hero.  In this episode, the simple question is asked:  how do you know if you're the villain?And I get into the importance of the No Kings movement and extremism in modern America.In a positive(-ish) way.  Love,-T

I greet you in Jesus' precious name! It is Thursday morning, the 16th of October, 2025, and this is your friend, Angus Buchan, with a thought for today. We start in the Book of John 1:17: ”For the law was given through Moses; grace and truth came through Jesus Christ.” Oh folks, what an incredible promise from God - grace!What is grace? Young man, young lady, you might ask, “What is grace?” Well, the definition of grace is undeserved loving kindness or unmerited favour. We can't earn it, we can't buy it, it is free! It is given to us by our Heavenly Father through His Son, Jesus Christ.The most famous scripture verse in the whole Bible is John 3:16:”For God so loved the world (you and me) that He gave His only begotten Son, (only one, no other) that whoever believes in Him should not perish but have everlasting life.” What a promise!When I became a new Christian, it was a long time ago, not far off fifty years ago, I remember one day walking through my maize crop and I was carrying all the burdens of the world on my shoulders. I felt totally unworthy to receive such a gift from God. I had just given my life to Jesus, and then the penny dropped. The Lord impressed upon my heart, “You've given your life to me, you've given your family to me, you've given your farming business to me. So now I am in control and you are purely a manager.” You know, you cannot believe how the weight fell off my shoulders. As they say, the penny dropped, my eyes were opened. I realised what grace was all about.We can't earn our way to heaven. Yes, we have the Ten Commandments as I shared just recently, and they are to be obeyed, but they cannot be obeyed without the grace of God and I was free. So if a storm came over and destroyed my maize, which was my only source of income in those days, “That was fine, Lord, what have You got next for me?” If I had sick child, I would pray for the child and leave the child in God's hand, so that the absolute responsibility was passed on to Jesus Christ.When He died on the cross He said, ”It is finished.” Everything is completed. Now, what we need to do is go out and tell the world that Jesus has paid for all our sin. All we have to do is to believe that He has done it and to wait for His soon coming.Jesus bless you and have a wonderful day, Goodbye.

Tu rêves de lancer un business à côté de ton job, mais tu ne sais pas si tu dois en parler à ton boss ou tout faire en douce ?Tu ne veux pas te griller, et tu aimerais savoir combien tu pourrais vraiment gagner ?Pour ce nouvel épisode de Solo Nation, je reçois 3 entrepreneurs qui se sont tous lancés en salariés diversifiés :✔️ Sarah Zitouni qui a tout dit à son boss et a négocié un 80% pour développer PowHER ta carrière en side✔️ Pauline Clavelloux, qui a joué la carte de la sécurité avec une lettre officielle avant de se lancer dans la création de logiciels Saas✔️ Kevin Jourdan, qui a commencé en scred total !

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog If you ever doubted your doctor because she wrote a script that you later “Googled” and found was not FDA approved, I hope you trusted your doctor enough to realize that she wouldn't recommend any medication that would hurt you…. What is an unapproved use of a drug, also called “off-label”? Unapproved use of an approved drug is often called “off-label” use. This term can mean that the drug is: Used for a disease or medical condition that it is not approved to treat, such as when a chemotherapy is approved to treat one type of cancer, but healthcare providers use it to treat a different type of cancer. The drugs that are not approved by the FDA, yet are commonly used, have been used for decades before the 1964 law that required new drugs to go through extensive and very expensive testing before their release to the public. The operative word is NEW DRUGS AFTER 1964. Today I will talk about the safety of non-FDA approved drugs because they are: Older cheaper drugs used for many diseases and conditions before 1964 and are still used Drugs that are approved for one use, or one condition, but not for other conditions that it is effective and safe for. Drugs made by compounding pharmacies for diseases that the FDA has not approved a drug for, but there is research backing the drug and years of safe use. First, before we discuss the non-FDA approved drugs, I will discuss the safety/risks of FDA approved drugs, and why FDA approval doesn't mean a drug will do no harm or even that it is effective for the use it is approved for. A little background will help you understand the problem and the reason an FDA approval does not necessarily mean a drug is safe.  Since 1964, a law was passed that established testing prior to a drug being approved by the FDA became mandatory.   Since that time several drugs that survive FDA approval and are released but are later removed or banned after their FDA release when the public finds side effects that the FDA didn't discover in their trials. One such drug is Fen-Phen, Fenfluramine/Phentermine. This drug was released during my time practicing medicine and was withdrawn after one study claimed it caused heart valve disease…In the end the “one post approval study” that claimed that heart valves were affected by this drug that caused its bann was found to be false. The withdrawal of the drug followed one study by a single cardiologist from Kansas City had reviewed all of the cardiac valve echo tests and falsified the results to make Fen-Phen appear dangerous to heart valves, when in reality it wasn't.  She lost her license, but the FDA never put Fen-Phen back on the market!  The FDA hates to be wrong twice, so they never allowed this drug back on the market after its removal. Other mistakes made by the FDA include not allowing women in the studies to approve a drug before 2014 which ignores or misses all of the side effects or lack of effectiveness for a drug when taken by women.  Despite all the expensive testing before the release of a drug by the FDA, many drugs not tested on women were later often found to have severe side effects only on women. A few examples follow: You might have heard of the FDA approved drug Ambien that causes many women to experience “night eating”, sleepwalking, and night terrors, while their male counterparts were not affected, so because they only tested men the drug was approved. In retrospect it should have been tested on women as well, and then either not passed through the FDA or should have had a black box warning for women. It takes years get action from the FDA, notifying doctors of these side effects. Women were not included in testing for any drugs except female hormones until 11 years ago, but no other drugs.   Before 2014 all (non-hormonal) drugs that passed the FDA were not tested on women so the effect on women was unknown until it was tested on the public. The FDA left women out of drug-trials because it viewed women as “mini men”, or they didn't consider us important enough to test new drugs on…OR worse, they believed we were too complicated to easily test us because of pregnancy, menopause and other hormonal swings that normal healthy women have.  In any case, we are now suffering their decisions, when a medication works one way for men and another way for women! Finally, we are tested when drugs are being evaluated for approval by the FDA. Professional women have achieved a level of authority in medicine and pharmacology (2025) and are weighing in on the inequity. Women in the medical profession and the public are pulling back the curtain on the side effects of FDA approved drugs that are experienced by women only! Slowly, study by study investigators are now publishing the side effects and problems for women with FDA approved drugs….yet these findings are not included in the warnings on most of these drugs, even now over 15 year after they became obvious to the doctors who treat women! Drugs that either don't work for women, or that have severe side effects include that were approved before 2014. All statin drugs for high cholesterol (Crestor, rosuvastatin, atorvastatin, etc.) cause women to have muscle breakdown and muscle pain. Synthroid (levothyroxine), doesn't cure the symptoms of hypothyroidism in 80% of women, but just makes the TSH lower, so it appears as if it is working! This leads doctors to tell women that their symptoms are all in their heads!! Wrong.  It is the wrong medicine. Women have enzymes that differ from men that make it difficult for them to convert the inactive form (T4) into the active form (T3), so we can't convert Synthroid (all T4) into the active form. Synthroid, the FDA approved drug for hypothyroidism, shouldn't be given to most women. Women should be given the non-FDA approved drug Armour Thyroid or NP thyroid that have both T3 and T4 in them! Ambien Prednisone and other oral steroids We have reviewed the lack of testing on women before 2014, now we will discuss safe drugs that have been used for decades even before 1964 when the FDA required testing for FDA approval? Older, yet effective and inexpensive drugs have been tested by the public, some for almost 100 years that have saved thousands of lives, yet they are not given the FDA stamp of approval!  In fact, the FDA tries to put these drugs out of circulation, replacing them with very expensive drugs that are new! Or they just shut them down, because they are not FDA approved.  Young doctors are told not to use them by their medical schoolteachers who rarely have experienced these medications in private practice…. These doctors in training don't know the history of older safer, cheaper drugs, or even why the FDA tells them avoid them. They comply not knowing why, so you are left with no drug that works for you, or you pay 3-10 times the amount for a newer FDA version of the older drug which may even have more side effects. Some of these older very effective and cheap drugs are Penicillin, Nitroglycerine for chest pain, Morphine (pain), Phenobarbital (seizures), Codeine, Armour Thyroid, hormone injections including estradiol injections and testosterone, Thorazine for psychiatric use, (Pitocin) oxytocin for labor, lactation support and Autism Colchicine:Used to treat and prevent gout. Progesterone in oil (IM) Estradiol in oil (IM) B12 for injection Testosterone Cypionate for injection Compounded Estradiol in any form Compounded Testosterone for women These drugs have been used for so long that any safety risks or side effects have been found through the use of these drugs in the population. Yet the FDA won't grandfather them in and approve them based on their history! What do doctors do when the drug the FDA has approved a drug that doesn't work for a group of their patients (gender, race, blood type, etc.)?  What happens when a doctor can't find a drug that is FDA approved needed to treat a condition she is faced with? Why do we as citizens, allow the government to have power over doctors who are already controlled by their state licensing boards as to what medications they?  Lastly Why do taxpayers allow a government agency that they fund with tax dollars control their health by banning, or not approving drugs, or banning one drug so an outrageously expensive drug is put in its place? Compounded Medications/ Compounding Pharmacies: These drugs are made by mixing ingredients to meet individual patient needs and are not subject to premarket review for safety, effectiveness, or quality. However, they ARE subject to the success or failure for which they were prescribed. If a doctor prescribes a compounded drug that doesn't work, she is apt to be confronted by her patient who is not getting the expected results.  Compounding pharmacies usually don't get paid by insurance, so patients are more invested in getting a drug that works and that is one of the big reasons that Compounded medicines are at least as good or better than big pharma or generic drugs. I absolutely could not successfully treat the thousands of women and men that I have without compounding pharmacies.  They compound hormones/drugs that are safe and effective, mostly hormones that can't be patented because they occur in nature and won't ever be made by big pharma. More than that, big producers of drugs can't produce in mass quantities many doses of a certain hormone like compounding pharmacies do.  Compounding pharmacies provide what people need and they continue to do so because patients prefer their dosing and quality.  FDA approved Generic Drugs can be legally 25 % lower dose than what they say they are.  That would be a big problem if my compounded pellets had that kind of variability. People might need pellets every 2months or every 5 months instead of every 4 months..it would be like guessing what you need ahead of time…..I believe dedicated compounding pharmacists are more accurate than any generic on the market. Compounding pharmacies: Unsung Heros Compounding pharmacies serve the public when big pharma fails and hasn't developed a safety net for production if they have a problem and the FDA shuts them down. That situation leaves patients who take their medications, without an alternative. Compounding pharmacies step into the breech when big pharma has a problem with a particular drug and stop making a drug (e.g. Lidocaine, B12 injectable, IV Fluids, to name a few shortages and no production that have occurred in the recent past). What if patients couldn't get the meds they need, and if there were no compounding pharmacies—Chaos and suffering and dying patients would closely follow! The FDA is Fickle and is not on your side! For years the FDA did not approve of Bioidentical estrogen and testosterone in any form, and just a few months ago all of a sudden, long after they scared women from taking the hormones they needed to improve their length of life and quality of life, they decided bioidentical hormones are better than the FDA approved hormones!!!  That is a little too late.  Some of us will never forget the stress lack of approval of compounded hormones caused for doctors and patients alike.  Other doctors criticized us and now most of them aren't even in practice anymore.  Maybe the FDA read my blog!!! Compounded hormones have been approved by the masses of women who have taken them under my signature! Compounded BI hormones are medications with a long track record and should not have to be tested with the bloated expense required of testing for the FDA. For Gynecological Disorders that don't have an FDA approved hormone drug because testosterone and estradiol have been used for so long that they don't need testing. If there was a significant problem with them their history of use of over 5-7 decades has proven the efficacy and safety of the female hormones for treatment and hormone replacement. For Psychiatric Disorders: Some patients need compounded ketamine products for conditions like severe depression, despite lacking FDA approval for these uses and potential risks, yet it has been used for this purpose for decades and was used for childbirth for almost a century, until epidurals and saddle blocks took their place. Testosterone for women still is not recognized as a female hormone even though women produce over twice as much Testosterone as Estradiol when they are in their fertile years.   Replacement of T with bioidentical T pellets offers a treatment for dozens of symptoms women face after age 40, and it prevents the diseases of aging: osteoporosis, heart disease, sarcopenia, frailty, diabetes and more that have not been addressed by mainstream medicine and the FDA. Over a decade ago, the FDA turned down the approval of testosterone patch after over 3 years of positive research studies, the FDA said they didn't approve T for women is because the side effect of T for women, facial hair, was dangerous for women.…I cry B—–S—-!  That is really men not wanting to share testosterone replacement with women. I say leave us alone and let women and their doctors determine what they need.  It is proven that only 5% of all professionals in any profession are not trustworthy, so give doctors their due and trust that we are looking for answers to our patients' problems that you don't even know about! The FDA is paid for by us…everyone in this country. I say hands off! Speed up the approval process or forget it for older drugs and BI hormones! ~

“MoneyBagg Yo raps like me… I was rapping first” ~ J Sipp  Meridian, Mississippi artist J Sipp sits down for a Skipping Class interview with host Lalaa Shepard to talk about coming up in the game, starting music at age 9, and doing a record with DG Yola before he got locked up. J Sipp also explains why he'd never go into the club business after learning directly from his dad, how he stays motivated, and his unique MoneyBagg Yo-like sound. He opens up about attending school for audio engineering, working with artists like J Money, DG Yola, Webbie, and Derez Deshon, and giving back to his community through partnerships with the Boys & Girls Club. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's show covers breaking updates out of the Middle East as Hamas faces growing international pressure and hostages remain unrecovered. President Trump honors Charlie Kirk with the nation's highest civilian award in a powerful and emotional ceremony. Plus — SCOTUS rejects Alex Jones' appeal, leaked messages shake up GOP youth groups, Candace Owens is banned from Australia, and Sunny Hostin tries (and fails) to smear RFK Jr.SUPPORT OUR SPONSORS TO SUPPORT OUR SHOW!Give your furry friend the gift of healthy, happy skin this season—save 15% on all Coat Defenseproducts at https://CoatDefense.com with code CHICKS at checkout!Be proactive with your health— go to https://AllFamilyPharmacy.com/Chicks and use codeCHICKS10 to get 10% off your order today. Ivermectin and Mebendazole are 25% off.Ready to try MASA Chips? Visit https://MasaChips.com/CHICKS and use code CHICKS for25% off your first order!Get 50% off your first box plus free shipping and free dessert for life with Home Chef athttps://HomeChef.com/chicks—must be an active subscriber for free dessert.Get your free Jumpstart trial bag, just pay for shipping, and check out Dr. Black's new book.Visit https://RuffGreens.com/Book to purchase your copy today!

This week on The Next Level Jonathan V. Last, Sarah Longwell, and Tim Miller discuss the GOP's accelerating moral collapse. MAGA wants to discredit No Kings protests as “Hate America” rallies, and a racist Young Republicans group chat leak shows how deep the rot goes. They explore how Kristi Noem's taxpayer-funded ad blitz crosses every ethical line and what it says about ICE's power in the administration. Plus, they debate whether establishment Democrats are sabotaging the party's Senate chances by pushing candidates they feel are safer bets. 

Rush Hour Podcast – Morning Edition Today's Rush Hour Podcast dives into all the top stories heating up the headlines

On Tuesday, what would have been Charlie Kirk's 32nd birthday, President Donald Trump posthumously awarded the Turning Point USA (TPUSA) co-founder the Presidential Medal of Freedom, solidifying his enduring legacy of promoting faith, family, and patriotism. TPUSA Chief Operating Officer Tyler Bowyer joins the Rundown to reflect on Charlie's impact, the organization's continued momentum, and efforts to strengthen event security in coordination with law enforcement. Instagram content for teenagers is about to become less "R-rated" thanks to new AI technology. Fox Business correspondent Madison Alworth joins the Rundown to talk about Meta's new restrictions and policies for teenage users, including the adoption of a PG-13 rating system, automatic enrollment of teenagers into "teen accounts", and additional parental control features. Plus, commentary by Dr. Marc Siegal, Fox News Senior Medical Analyst. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This is a free preview of a paid episode. To hear more, visit www.thebulwark.comThis week on The Next Level Jonathan V. Last, Sarah Longwell, and Tim Miller discuss the GOP's accelerating moral collapse. MAGA wants to discredit No Kings protests as “Hate America” rallies, and a racist Young Republicans group chat leak shows how deep the rot goes. They explore how Kristi Noem's taxpayer-funded ad blitz crosses every ethical line and what it says about ICE's power in the administration. Plus, they debate whether establishment Democrats are sabotaging the party's Senate chances by pushing candidates they feel are safer bets. Watch, listen, and leave a comment. This ad-free video version of The Next Level is exclusively for Bulwark+ members. You can find The Next Level wherever you get your podcasts and on YouTube. Add The Next Level to your podcast player of choice, here.

https://revengeofthecis.locals.com/    

10-14 Stanford GM Andrew Luck discusses Homecoming & his thoughts on what young QBs need to learn and take away during 1st years in NFLSee omnystudio.com/listener for privacy information.

"What did Young Tony ask today?" - Murph & Markus discuss their worst sports injuries, what former Bay Area athletes they want to see fail the most, & moreSee omnystudio.com/listener for privacy information.

10-14 Stanford GM Andrew Luck discusses Homecoming & his thoughts on what young QBs need to learn and take away during 1st years in NFLSee omnystudio.com/listener for privacy information.

Murph & Markus - hour 2: "What did Young Tony ask today?," Duane Kuiper joins the show, & do you still believe in the 49ers?See omnystudio.com/listener for privacy information.

"What did Young Tony ask today?" - Murph & Markus discuss their worst sports injuries, what former Bay Area athletes they want to see fail the most, & moreSee omnystudio.com/listener for privacy information.

Murph & Markus - hour 2: "What did Young Tony ask today?," Duane Kuiper joins the show, & do you still believe in the 49ers?See omnystudio.com/listener for privacy information.

Is your founder story costing you sales? Young entrepreneurs, it's time to shift the focus from you to your customers. In this empowering episode of Young Boss, Isabelle Guarino breaks down why leading with your personal story could be hurting your business and how to craft messaging that drives results. Learn the four essential pillars (big idea, big benefit, big promise, and proof) that will transform how you communicate your value and connect with your audience.  Packed with inspiring conversations, practical advice, and unique experiences, this episode is a must-listen for anyone ready to level up their entrepreneurship game. Discover how to make your customer the hero of your business journey and why "youth is your power" when it comes to building a brand that grows and thrives. From actionable insights to proven strategies, you'll walk away with tools to refine your pitch, market effectively, and create lasting customer relationships.  If you're ready to stop talking about what you built and start showing how you change lives, this episode is your guide to success. Like, share, and follow us on Instagram and TikTok for more lessons, success stories, and financial literacy tips. Don't forget to subscribe on YouTube and Spotify to stay inspired and empowered on your journey as a young boss!CHAPTERS:00:00 - Intro00:58 - Understanding Customer Needs04:21 - Founder's Essential 4 Pillars07:58 - Guest Directory Overview08:38 - Real World Application of 4 Pillars11:17 - Embedding Your Messaging Strategy12:58 - Final Challenge for Founders14:04 - Conclusion and ThanksSubscribe to Young Boss with Isabelle Guarino wherever you get your podcasts, and be sure to like, share and follow on Instagram and TikTok.And remember, youth is your power.

Mark Peters is the Chief Executive Officer of Butterball Farms, Inc., which was nationally recognized as one of The Best and Brightest Companies to Work For® from 2018 to 2025. Most recently, named a Top 101 Companies to Work For® in the nation. The second-generation family business, based in Grand Rapids, Michigan, is America's leading producer of culinary butter and margarine and creates custom butter flavors for some of America's biggest brands.  Peters began as a factory worker in his father's company at the age of 12: an experience that taught him first-hand about the challenges that frontline workers face. At 30, he took over the company determined to lead a financially successful business that would also enrich the lives of its workers. In 2003, he organized a pioneering group of CEOs and community leaders to found The SOURCE, a not-for-profit organization that has helped hundreds of workers navigate personal challenges that were interfering with their jobs and delivered an average annual return on investment of 200 percent to its partner organizations. This West Michigan-based model has been replicated in nearly 12 states; and Peters is currently expanding its mission to help frontline workers not only maintain their jobs but progress into better positions within or across partner companies.  His second book, The Retention Trap,  was published June 3 of 2025 and highlights the need to rethink talent and focus on investment rather than retention. Recognized by numerous companies from Ernst & Young to McDonalds for his leadership, Peters is an engaging speaker and storyteller who has addressed TED-x and other audiences. He lives in Grand Rapids with his daughter and dog and is an avid boater, biker, and skier. To know more about Mark visit his website: www.i-3leadership.com

Andrew Walworth, Tom Bevan and Carl Cannon discuss the scandal concerning racist and antisemitic remarks made on a private Telegram chat by leaders of The Young Republican National Federation. They also talk about President Trump's meeting yesterday with free-market economist, rock singer and Argentinian President Javier Milei. Trump promised $20 billion in loans to help Argentina's struggling economy conditioned on Milei's succeeding in upcoming elections. Then, they discuss the meaning and methodology of a new study that suggests the percentage of young Americans who identify as non-binary has fallen dramatically over the past few years. And lastly, they chat about the proposed plans to build what is being called the “Arc de Trump,” a 99 foot high memorial arch sited across the Potomac River from The Lincoln Memorial to mark America's 250thanniversary on July 4, 2026. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week we're getting real about growing pains... from friendship breakups to navigating totally different communication styles with your partner. And that big question everyone keeps asking: am I too young to have found my forever person? Welcome back to The Groupchat besties!!!In The Groupchat, we share some of your TMI & embarrassing stories that always leaves us on the end of our seat and crying of laughter! We share our advice around YOUR dilemmas and help you navigate different situations in life from dating, friendship, family, life & everything in between! As always your secret is safe with us and whatever happens in The Groupchat stays in The Groupchat!If you'd like to join The Groupchat and share any TMI stories, have your say in our dilemma debates or need any advice please DM or email us from the below: Instagram: @thegroupchatTik Tok: @the.groupchatpod Email: hello.thegroupchatpodcast@gmail.com follow Liv on socials: Instagram: @oliviamesciaTiktok: @oliviamesciafollow Ash on socials:Instagram: @ashleymesciaTik Tok: @ashleymesciaSee you next Thursday xx*We'd like to acknowledge the traditional custodians of this land in which we are able to record this podcast. We would like to pay respect to elders past, present and emerging and any aboriginal and Torres Strait Islander people here today.* Hosted on Acast. See acast.com/privacy for more information.

Messages from a leaked group chat obtained by Politico show members of Young Republican groups from New York and across the country using racist, sexist, and antisemitic slurs. The outlet reports several members have since lost their jobs. Meanwhile, New York's power grid operator warns the city could face longer and more frequent outages over the next five years due to rising electricity demand and delays in new power generation. Also, officials in White Plains are urging the public to avoid the area around the Westchester shopping complex after a partial parking garage collapse forced multiple road closures. Plus, Politico reporter Jason Beeferman joins us later to discuss the fallout from the leaked messages.

Today, Luke discusses leaked texts from a young republicans group chat, Trump's comments on Karoline Leavitt, and more!Order your PEP now!https://drinkpep.com/Get connected below!Twitter - https://twitter.com/lukepbeasleyInstagram - https://www.instagram.com/lukebeasleyofficial/TikTok -https://vm.tiktok.com/TTPdSfpPHw/YouTube channel - https://www.youtube.com/channel/UCM05jgFNwoeXvWfO9GuExzAl

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common forms of muscular dystrophy, affecting individuals across the lifespan with variable severity. Advances in genetic understanding and therapeutic development have led to an era of promising disease-modifying strategies. In this episode, Katie Grouse, MD FAAN, speaks with Renatta N. Knox, MD, PhD, author of the article “Facioscapulohumeral Muscular Dystrophy” in the Continuum® October 2025 Muscle and Neuromuscular Junction Disorders issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Knox is an assistant professor of neurology in the Division of Pediatric Neurology and Neuromuscular Section at Washington University School of Medicine in St. Louis, Missouri. Additional Resources Read the article: Facioscapulohumeral Muscular Dystrophy Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN  Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Renatta Knox about her article on fascioscapulohumeral muscular dystrophy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Welcome to the podcast, and please introduce yourself to our audience. Dr Knox: Hi Katie, thank you so much for the invitation for the audio interview. I'm looking forward to our conversation. As she mentioned, my name is Renata Knox. It's a pleasure to be here today. Dr Grouse: I'd like to start by asking, what is the key message that you hope your readers will take from your article? Dr Knox: I would say two things. The first is an appreciation and understanding of the unique genetic mechanism that leads to FSHD. And the second is the really exciting therapy landscape that we find ourselves in. So, we're hopeful that there will actually be disease-modifying therapies for FSHD soon. Dr Grouse: We're really looking forward to learning more about that. Now, before we get to that piece, could you just remind us of the clinical manifestations and features that are specific to FSHD? Dr Knox: So, one of the most unique things about FSHD that we see clinically is the pattern of weakness. So, one of the first features is that it's asymmetric. And then there are certain muscle groups that typically are affected, and that's partly where the name comes from. So, we see effects in the face, the limbs, the trunk; and so, those are some of the unique features that we see clinically. Dr Grouse: I'd love it if you could walk us through how you approach diagnosing a patient who presents with proximal weakness where FSHD is in your differential. Dr Knox: Yeah, it's a really great question. So, I would say it depends. So, I actually focus on FSHD in my clinical practice. So, many times patients are referred to me because there's a very high suspicion or there's a known family history of FSHD. So, that's one category of cases. I would say the other category of case is where it's, as you said, maybe more proximal weakness more broadly. Someone that's before me who has a known family history, they really have some of the characteristic physical features---which I'm pretty attuned to, as this is, you know, part of my subspecialty---I'll actually go directly to FSHD genetic testing. And that is one of the unique features of this disease, that the next-generation sequencing panels that are typically used for some of our other muscle diseases, FSHD is not captured on those. So, we actually have to send targeted testing for FSHD to diagnose it. So, that is one category where, again, I have a very high suspicion either based on their clinical presentation and/or a known family history, then I will actually go directly to FSHD-targeted genetic testing. In the second case, where it is one of the conditions that I'm considering among others, I will do more broad testing. So, I will get a CK level to see if there's evidence of muscle breakdown. I'll likely also do one of the next-generation sequencing panels that we have access to, which will allow us to identify, potentially, one to two hundred potential muscle diseases. And then again, if FSHD is higher on my differential in that second group of patients, then I will also send targeted FSHD-specific testing. Dr Grouse: That's really helpful. And I'm wondering if you have any thoughts about common pitfalls that you've seen when providers are trying to work this up? Dr Knox: I don't know if I would say pitfalls. I think I would acknowledge that it's challenging. My subspecialty training in neuromuscular medicine and also gene therapy. And so FSHD is pretty high on my radar. But I would say in neurology in general---and then, you know, the general medical population---,it really isn't something that many people are seeing. So, I would say what patients will communicate to us sometimes is some frustration that maybe it took time to make the diagnosis, but I just have a deep understanding that it's not something that is on many people's radars. And I think, again, it's tricky because it's not picked up on these next-generation sequencing panels, which many of us can send pretty easily. It will be missed. And I will say the biggest pitfall is, again, if you're not thinking about it and you don't send that testing, you actually- it's very difficult to diagnose it. Dr Grouse: Thank you so much for highlighting that. I think there are many people who are not aware that those different panels really aren't picking that up and that they have to test specifically. So, I think that's a great thing for all of us to keep in mind. Are there any tips or tricks to the diagnosis, other than the genetic issues that you mentioned, that sometimes can really bring this diagnosis to the forefront? Dr Knox: I think things that really tip me off to having a higher suspicion for FSHD is facial weakness that we can detect on our exam. Scapular winging---again, there's a small subset of disorders which can impact that. Someone who's presenting with foot drop, you know, with facial weakness, I think definitely about FSHD more. Also, clinically, kind of the presentation or things that they're beginning to have difficulty with is a tip-off. So, if someone is an athlete, like, they're a volleyball player or basketball player and they say, oh, I'm having difficulties, you know, with movements that require them to elevate their arm, which can be a sign of the shoulder weakness that we classically see. Or someone who says, oh, I'm having a harder time shampooing my hair or combing my hair. So those can be tip-offs again, which are basically referencing the type of weakness that they have. Another feature of FSHD which isn't necessarily as broadly appreciated is that pain and fatigue are very common. So, if someone is coming in and saying, actually, I also have a significant amount of fatigue as well or a lot of pain, that's something that can tip me off to it. Hearing loss is something that we can also see in up to 20% of patients with FSHD. So, if they are having those symptoms or saying they're ringing in their ears, these are some things that will make me begin to think about it more. Dr Grouse: Oh, really helpful. I also found it really fascinating reading some of the very FSHD-specific clinical signs, some interesting- some diagrams and pictures as well, that are very specific to the pattern of weakness that develops in FSHD. So, I encourage our listeners to check that out. But are there any highlights from those little clinical pearls that you'd like to point out? Dr Knox: I think the poly-hill sign---so, these are these literal hills that we can see in the shoulders of patients with FSHD---is pretty classic. Popeye arms, which is this older term that we still use that has to do with which muscle groups are preserved versus those that have atrophy. So that's a common feature. And then I would say, really, the asymmetry is something that is a unique feature in FSHD. And again, we did our best to provide good representative images. So again, as you mentioned, Katie, I would really encourage people to look at those images and then think about cases that they may have seen and how similar they are so they can begin to recognize those signs as well. Dr Grouse: Now going back to the genetic topic, the complex genetic underpinnings of FSHD are really well-explained in your article; and again, worth taking a look at to remind ourselves of everything that's of that pathology. Now, I was wondering though, if you could give us a brief overview of how we should approach genetic testing in a suspected case of FSHD? You mentioned some specific panels, but it does sound like there's some more complexity to it as well. Dr Knox: Yes, and I'll just kind of briefly explain that complexity. Part of the thing that we're detecting in the genetic testing is the repeat number. And so, we're actually looking for a contraction in a repeat number. So, not an expansion, which were typical for some of the diseases that we think about, the trinucleotide repeat disorders. And this is why it's not captured in the next-generation sequencing panels, because they do not currently have the ability to do that. And so, again, what the type of testing that I do really depends on my suspicion. So again, if my suspicion is very high for FSHD---they have a family history, they have the classic features---then I will actually go directly to an FSHD-specific testing, which is available from various sources. If, again, it's among different things that I'm thinking about, I will get a CK lab. I typically will also send a next-generation sequencing panel specific for muscle diseases, perhaps muscular dystrophy; again, depending on what I'm thinking about. And then I will also send in a specific FSHD genetic test as well. People are beginning to use whole-genome sequencing, which is capturing some of our true nucleotide repeat disorders and becoming more comprehensive. So, my hope is that as that becomes more standard of care---like, whole-exome sequencing can be gotten pretty routinely now---that it may be easier for us to make some of these diagnoses. Dr Grouse: Well, that's really helpful, and thanks for that overview. Now another thing that you mentioned that I thought was really interesting in your article was that patients with, you know, history of FSHD, perhaps in the family, who are pregnant and want to screen for this disease would not be able to use sort of the more common screening tests like cell-free DNA testing and may have to go to other means to do that. What is generally their route to this type of testing? Dr Knox: Yeah, great question, and really important question for family planning purposes, and it definitely comes up in clinical practice. And so again, because of the unique genetics of FSHD, you actually have to do invasive genetic testing currently to be able to test it. And so that's, you know, amnio or chorio, and then send it to a lab that can perform, again, FSHD-specific testing on the samples that are presented. And there are obviously labs that are capable of doing that and centers that are capable of doing that, but it is not picked up on the cell-free DNA panels that are being very routinely used. You or your provider has to be thinking about it to send that specific testing, similar to our patients that come into clinic and have not yet been diagnosed. Dr Grouse: Once you have the diagnosis, what are our options for therapy? I think it sounds like at this current time, it looks to be mostly supportive. What are some of the supportive care options we should keep in mind? Dr Knox: Yes, so that is definitely accurate. Care today is supportive, but again, we're very excited about the clinical trial and therapy landscape for FSHD. So, I work very closely with my physical therapy colleagues that are in clinic with me. So, we work very closely with physical and occupational therapists to help with supportive measures, adaptive measures, doing assessments, helping our patients to be able to move and exercise safely and effectively. As I mentioned, pain is very common in FSHD and so we can treat that with medications. The most common medication that we use to treat for pain in FSHD are NSAIDs. And then other than that it's really, you know, supportive measures. Do they need to see other subspecialists? There are some surgical options. Those are used very rarely to help with some of the scapular weakness, but typically it's physical therapy, occupational therapy, supportive devices. We treat the pain as we're able to, and then we work with other subspecialists to screen, monitor and support our patients to the best of our ability. Dr Grouse: Well, without further ado, I'd love to hear more about what's coming down the pipeline in clinical trials. What can we look forward to seeing, hopefully, in future years to treat these patients? Dr Knox: Yes. And so, this is actually what got me interested in the neuromuscle space in general is that, because we now for many years have known the genetic cause of many of these disorders as well as some of the underlying mechanisms, we can actually use advances in therapeutics to do what we call targeted therapies. So, rather than treating symptoms or indirect methods or doing kind of broad drug screens---which, again, still do take place and still do have their place---we actually can target mechanisms directly. And so, we know that the underlying biology of FSHD is due to this protein called DUX4 being expressed when it should not be. So, it's what we call a toxic gain of function. And so, the targeted way to address this is to suppress DUX4 expression. And so, kind of broadly speaking, what we're really excited about are a couple of products that are currently in clinical trials right now that actually caused DUX4 suppression to be suppressed. And again, these are targeted pathways. And so, again, the hope is that by doing that, we can hopefully slow the progression of the disease, potentially stop progression of the disease, and potentially reverse. Again, we don't know if that might be possible, but that is one of the hopes. Dr Grouse: Well, that's really exciting, and I know we're all looking forward to more coming down the pipeline soon, and hopefully more things that can really offer some exciting treatments for our patients with this condition. Now, a little more deep-dive into our patients who are diagnosed. You've reviewed some of the treatments currently available and hopefully may someday soon be available. Are there other things that we should be keeping in mind in this population? For instance, screenings that we should be doing for other extramuscular manifestations that we need to be thinking about? Dr Knox: I will answer that question two ways. I think something that's very important to acknowledge is the impact that these diagnoses and these conditions have on our patient practically, psychologically. One of the other unique features of FSHD is, it's autosomal-dominant. So, if it is in a family, you can have many family members who are affected, but the variability is very high. And so, you can have in the same family someone who is wheelchair-dependent, and someone else in the family with the same underlying genetics who has no signs or symptoms or is very mildly affected. And that is something that is definitely challenging for our families and patients to navigate if they're very different than their family members with the same condition. And just navigating the world with a condition that, you know, can be physically debilitating and cause changes to what they're able to do or not able to do, progression is something that's very difficult to handle. So, I think that's one set of things. And we try our best, you know, with my team and my other colleagues in the space, to support our families and patients in the best way that we can. Secondly, there is very important screening that needs to be done for this condition. So, one of the things- and the current guidelines which are actually being updated, the last update was in 2015 is all patients that undergo pulmonary function testing or PFTs. And so that's something we do at baseline and we do at least annually in my practice. Young kids who are presenting very early or patients with certain genetics that we know are more predisposed to extra muscular manifestations, we recommend screening for hearing, which is one of the manifestations, and ophthalmologic exam to look for retinovascular changes, which is one of the manifestations as well. Those are the more common ones that are typically done. There's also some evidence in pediatric patients with very severe manifestations that there may be some cognitive impacts, learning impacts. And so, that is something we're also thinking about screening and supporting our patients in that way. And again, we typically work with these patients in a multidisciplinary team depending on what manifestations and the degrees to which they're impacted by the disorder. Dr Grouse: Thank you so much for that answer. I think a lot of us forget sometimes when we get really focused on what can we do now, that we forget to kind of stop and reflect on sort of the more holistic approach. How is this affecting the patient? How is this affecting the patient's family dynamic, and what other ways are they going through life with this condition that we need to be thinking about? So, I appreciate you bringing that up. I wanted to ask, sort of based on what you're talking about and what you mentioned already, you happened to mention that what initially drew you that to this work was your interest in some of the really exciting breakthroughs in the field. Well, was there anything else that drew you to, specifically, congenital neuromuscular diseases, and FSHD in particular? Dr Knox: I'm a physician scientist by training, and so I would describe myself also as a molecular biologist. So, I love getting into the nitty gritties of disease mechanisms, what genes are doing in bodies, how they function. And so, as I mentioned earlier, in the neuromuscle space, we've known for many years the genetic cause of many of these disorders and have done great, you know, mechanistic work to kind of define why we see the disease. And then now we're at this intersection of that knowledge marrying with these really novel therapeutic approaches, gene therapy approaches, being able to intersect and then in very creative ways actually target diseases very directly. And so, I would say it really is the combination of those two things. FSHD has a really fascinating unique biology, which again, we encourage everyone to read about more in the article. That really drew me to it. I'm very interested in gene regulation, transcription. This is one of the underlying mechanisms that is gone awry in the disorder, and then that being married to advances in therapeutics. So, you could wed those two pieces of information and actually meaningfully impact patient 's lives. And again, that's the real privilege and honor to witness is how these therapies can transform lives. And I saw it happened with this one case for this one disorder when I was a resident where there was no treatment. Young children, unfortunately, would not survive the disease. And then I saw the therapy come be in development and literally change the trajectory. And this is what we're very hopeful for in the FSHD space, that wedding, this wonderful basic science research, translational research, companies working together to develop these therapies that can transform lives. It is just so beautiful to witness and see, and it's something that I get to do. You know, it's a part of my job, so it's a real privilege. Dr Grouse: Well, I have to say, it's really inspiring hearing you talk about it. And I imagine that many neurologists-in-training who are listening to this may be inspired as well and may be convinced to go into this field for that very reason. So, thank you so much for sharing all of this information with us today. I learned a lot, and I think all of our listeners have too. Dr Knox: Thank you. It's really been a pleasure. Dr Grouse: Again, today I've been interviewing Dr Renatta Knox about her article on fascioscapulohumeral muscular dystrophy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.